Overview

Use of DNAse in Neutrophilic Asthma

Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
In this pilot protocol, the researchers look to determine benefits from use of nebulized rh-DNase for 4 weeks in patients with neutrophilic asthma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Jewish Health